Table 1.
Study | Type of Study | Participants With Anticoagulants, n | Follow‐up | Participant Age, y | F Ratio, % | Major Bleeding Definitions | Quality Rating |
---|---|---|---|---|---|---|---|
Pisters 20106 | Prospective | 2242 | Mean, 1 y | Mean, 67 | 41 | NA | Good |
Fang 20117 | Prospective | 9186 | Mean, 3.5 y | NA | NA | ICD‐9 codes | Good |
Lip 201111 | Prospective | 3665 | Mean, 499 d | Mean, 72 | 39 | NA | Good |
Gallego 201212 | Prospective | 965 | Median, 861 d | Median, 76 | 50 | NA | Good |
Apostolakis 201213 | Retrospective | 2293 | Mean, 429 d | Mean, 70 | 35 | 2005 ISTH criteria | Good |
Naganuma 201214 | Retrospective | 845 | Median, 2.3 y | Median, 74 | 31 | NA | Good |
Friberg 201215 | Prospective | 48 599 | Mean, 1.5 y | Mean, 76 | 47 | ICD‐10 codes | Good |
Apostolakis 201316 | Retrospective | 2293 | Mean, 429 d | Mean, 70 | 35 | 2005 ISTH criteria | Good |
Roldán 201317 | Prospective | 937 | Median, 952 d | Median, 76 | 51 | 2005 ISTH criteria | Good |
Roldán 201318 | Retrospective | 1370 | Median, 996 d | Median, 76 | 53 | 2005 ISTH criteria | Good |
Barnes 201419 | Retrospective | 2600 | Mean, 1 y | Mean, 70 | 42 | 2005 ISTH criteria | Good |
Abbreviations: F, female; ICD, International Classification of Diseases; ISTH, International Society on Thrombosis and Haemostasis; NA, not available.